Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...

Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease Paris, March 18, 2026. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy ...

MINJUVI ® (tafasitamab) is a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody. Tafasitamab incorporates an XmAb ® engineered Fc domain, which mediates B-cell lysis through apoptosis ...

Additionally, MONJUVI received accelerated approval in the United States in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma ...

CorMedix (NASDAQ:CRMD) executives used a presentation at the Citizens Life Sciences Conference to outline the company’s focus on expanding its pipeline while integrating the recently acquired Melinta ...

China's healthcare system may benefit from the integration of home infusion therapy (HIT) combined with home health services (HHS) to address the urgent need for a sustainable long-term, post-acute ...

Star Trek IV The Voyage Home Movie (1986) Trailer - Plot synopsis: To save Earth from an alien probe, Admiral James T. Kirk and his fugitive crew go back in time to San Francisco in 1986 to retrieve ...

As employers look for new ways to make their healthcare benefits as effective and affordable as possible, two companies have partnered to bring infusion care closer to home. Processing Content ...

Curlee Thomas IV spent a whole lot of time away from home over the last few years while playing for Cal. The Fort Worth Nolan Catholic product decided to look for a new place to finish his college ...

The winter doesn't have to be short on its share of Atlanta Braves highlights. Saturday night saw Ronald Acuña Jr. have another big night at the plate, and his brother got in on the action. Both Acuña ...

Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve pressure on hospital beds - according to a University of East Anglia study.